Calusterone-d5

CAS: 17021-26-0

Ref. TR-C148902

Produktinformation

• Name: Calusterone-d5
• Synonyme: (7ß,17ß)-17-Hydroxy-7,17-dimethylandrost-4-en-3-one-d5, 7ß,17-Dimethyltestosterone-d5, 17ß-Hydroxy-7ß,17-dimethylandrost-4-en-3-one-d5, 7ß,17a-Dimethyltestosterone-d5, Methosarb-d5, NSC 88536-d5, U 22550-d5, (7Beta,17Beta)-17-Hydroxy-7,17-Dimethylandrost-4-En-3-One, (7b,17b)-17-Hydroxy-7,17-dimethylandrost-4-en-3-one, (7beta,8xi,17beta)-17-Hydroxy-7,17-dimethylandrost-4-en-3-one, 17021-26-0, 17β-Hydroxy-7β,17-dimethylandrost-4-en-3-one, 7.beta.,17-Dimethyltestosterone, 7b,17-Dimethyltestosterone, 7b,17a-Dimethyl-17b-hydroxyandrost-4-en-3-one, 7b,17a-Dimethyltestosterone, Androst-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7.beta.,17.beta.)-, Androst-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7β,17β)-, Androst-4-en-3-one, 17.beta.-hydroxy-7.beta.,17-dimethyl-, Androst-4-en-3-one, 17β-hydroxy-7β,17-dimethyl-, Methosarb, NSC 88536, Testosterone, 7β,17-dimethyl-, U 22550, Calusterone

Beschreibung

Applications Calusterone-d5 is the labeled analogue of Calusterone (C148900), a synthetic androgen epimeric with Bolasterone (B674970). Has been used in treatment of breast cancer. Controlled substance (anabolic steroid).
References Horn, H., et al.: Br. J. Cancer, 33, 336 (1976); Zumoff, B., et al.: J. Clin. Endocrinol. Metab., 44(6), 1203 (1977)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 321.51
• Formel: C₂₁H₂₇D₅O₂
• Farbe/Form: Neat
• InChl: InChI=1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16-,17-,18+,19-,20-,21-/m0/s1/i5D2,11D2,12D
• InChI Key: InChIKey=IVFYLRMMHVYGJH-BEOZZHQKSA-N
• SMILES: [2H]C1=C2C([2H])([2H])[C@H](C)[C@H]3[C@@H]4CC[C@](C)(O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC([2H])([2H])C1=O